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A B ST R AC T 
 
 
Hepatitis C virus (HCV) is a pathogenic entity which determines inflammation 
and liver damage through complex immune mechanisms. Although progress has 
been made in managing the disease course, chronic infection still remains a 
significant cause of morbidity and mortality to this day. Because both acute and 
chronic infection are often asymptomatic, chronic infection is frequently 
diagnosed when its complications have developed. In a small proportion of 
cases, the chronic infection does not develop, the immune system managing to 
cleanse the body from this silent pathogen in the absence of specific treatment, 
a process called spontaneous viral clearance, which occurs rarely, in about 20-
30 % of cases. A competent immune response that manages to eliminate the 
virus from the organism was associated with IL-28B genetic polymorphism, 
female gender, young age, which often lead to clinical manifestations of acute 
hepatitis after initial exposure. Environmental factors such as limited viral 
exposure also play an important role. These factors and the mechanisms 
underlying spontaneous clearance are not fully understood but their action is 
complementary. In this paper, we review the concept of spontaneous clearance 
of HCV and assess the factors that have been associated with this clinical 
outcome of the infection.   
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Chronic hepatitis C infection is a chronic hepatopathy 
produced by the Hepatitis C Virus, which is characterized 
by persistent inflammation of the liver tissue over a period 
of more than six months after initial exposure to the virus 
[1]. 
According to epidemiological data made available by 
World Health Organization (WHO), in 2015 there were 
1,75 million new infected cases (with a global incidence of 
23.7/100.000) and an estimated 71 million people living 
with chronic HCV worldwide. In 2015 the worldwide 
prevalence was 1%. In terms of distribution, the prevalence 
of HCV is heterogeneous, with differences throughout 
geographical regions, the highest prevalence being met in 
The Eastern Mediterranean Region (2.3%), followed by the 
European Region (1.5%). In 2015 there were 1.34 million 
deaths due to complications of chronic viral hepatitis, 30% 
of these infections having the etiological agent HCV [2]. 
Although the recognition that another pathogen may 
cause chronic hepatitis besides hepatitis A and B virus has 
been around for more than half a century, the etiologic 
agent of so-called „non- A non- B hepatitis” was first 
described only in the late 1980s [3-7]. 
Hepatitis C virus is a hepatotropic RNA virus that 
belongs to the extensive Flaviviridae family, the 
Hepacivirus genus [8]. Structurally it is composed of the 
viral genome (viral ARN), which is enveloped in the 
nucleocapsid and protected by a protein layer. 
HCV infection can be acquired through several 
pathways: parenteral, sexual, and maternal-fetal, the last 
being less common [9]. Once acquired, the acute infection 
is developed, which in the majority of cases is 
asymptomatic, thus explaining the low rate of early HCV 
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diagnosis.  In 20-30% of cases due to complex interactions 
between host, virus, and environmental factors, 
spontaneous clearance (SC) occurs, most often in the first 
six months after exposure [10]. Unfortunately, for the vast 
majority of cases, the acute infection evolves into a chronic 
one which, left untreated, can lead to liver cirrhosis as well 
as other complications [11]. 
Diagnosing HCV is a two-step process: the first one 
implies serological presence of HCV antibodies; the 
second, after the HCV antibodies are positive, a nucleic 
acid test for the virus RNA is needed to confirm the 
infection [12]. 
Discussions 
Spontaneous clearance of VHC 
The spontaneous clearance of HCV is a rare clinical 
event, but which has been observed and objectified in 
several specialized studies. As the name implies, it 
involves the eradication of the virus in the absence of a 
specific treatment.  From a serological point of view, 
patients who develop SC are characterized by the presence 
of anti-HCV antibodies in their serum and by the absence 
of HCV-RNA [13]. 
HCV SC is an incompletely elucidated clinical 
outcome determined by the complex interaction between 
host, environmental, and viral factors. 
1.    Host factors 
1.1. Interleukin-28B Gene 
IL-28B, together with IL-28A and IL-29, represents a 
gene cluster located on chromosome 19 that encodes 
elements of the immune response. IL-28B stores the 
information needed to encode interferon (IFN) λ3. 
INF-λ3 belongs to the INF-λ family, together with INF-
λ1 and INF-λ2, (which are encoded by IL29 and IL28A). λ 
interferons are considered type III interferons which play 
an essential role in the immune response triggered by a 
viral infection, being potent endogenous antiviral 
cytokines. They are mainly produced by macrophages in 
response to viral stimuli and can inhibit viral protein 
synthesis and replication by having similar biological 
activity with type I IFN (alpha and beta) [14]. 
Genome-wide association studies have identified 
polymorphism determined by a single nucleotide located at 
rs12979860 near the IL-28B gene, making possible three 
variants: CC, TT, and CT. The spread of the CC variant 
across the globe is heterogeneous, the highest incidence 
being among the Asian population [15]. 
The first associations between the IL-28B genetic 
polymorphism and HCV were observed analyzing the 
response to IFN-alpha treatment; at that time, patients 
presenting the CC subtype had a higher virological 
response rate. Currently, interferon treatment is outdated, 
but the importance of the IL-28B genetic polymorphism is 
not, an impressive number of studies associating the 
presence of IL-28B CC subtype with spontaneous 
clearance of VHC in the acute phase [16-19]. 
How the presence of CC genotype is associated with a 
better response to HCV infection is not fully known. The 
serum of CC positive patients is characterized by higher 
levels of IL-28B and higher levels of transaminases than 
the serum of CT or TT positive patients, suggesting that 
they have a more competent immune response. Several 
studies concluded that not only IL-28B levels were 
elevated but also IL-29 and IL-28A, implying that the 
presence of CC variant may have an impact on the 
production of all lambda type IFN [20]. 
This feature supports the importance of genetic factors 
and also genetic variability in the clinical outcome of VHC 
infection, patients with the IL-28B CC subtype having a 
higher probability of eliminating the virus in the absence 
of specific treatment [21]. 
1.2. Gender 
The importance of gender in the clinical outcome of 
viral infection is unknown, but it is has been observed, 
namely: Spontaneous clearance of HCV has been noticed 
more in females than in males; females have a better 
response to eradication therapy; in the chronic phase of 
infection men have higher levels of HCV RNA than 
females; cirrhotic progression occurs more frequent after 
menstrual cessation [10, 12-26]. 
The reason behind this different behavior of the clinical 
course is not fully known; some authors believe that sex-
specific hormones play a decisive role in this regard [27]. 
In that matter, it has been shown that 17β-estradiol, an 
important constituent of the female endocrine system, 
interferes with infection progress by inhibiting viral protein 
assembly and virus release from the hepatocyte [28]. 
A relatively new study concluded that estrogen exerts 
its influence even in the primary stages of the infection 
process, in that it inhibits virus endocytosis. It 
accomplishes this action by Occludin cleavage, a tight 
junction protein, but also an HCV receptor found at the 
hepatocyte surface [29]. 
1.3. Ethnicity 
The way in which race influences the clinical path of 
this disease has not been thoroughly examined, most of the 
results deriving from observational studies. However, 
taking into account certain genetic varieties found in 
different races, such as the genetic polymorphism IL-28B 
CC, which has the highest incidence among the Asian 
population, we can say that ethnicity is a factor that can 
influence the clinical course of infection. Several studies 
have shown an association between the higher frequency 
of SC in the Aboriginal population, but the underlying 
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cause remains unclear. An explanation could be found in 
the fact that individuals belonging to this ethnicity are 
characterized by the ability to produce lower levels of IL-
10, the cytokine that downregulates several immune 
actions, as well as by a more potent activity of "natural 
killer" lymphocytes. Of course, all of these facilities are 
determined by genetic factors, which remain the subject of 
many questions [30,31]. 
1.4. Symptomatic acute hepatitis 
As mentioned above, acute HCV infection is in most 
cases asymptomatic. However, when it becomes manifest, 
the symptomatology is polymorphic, ranging from 
asthenia, anorexia, abdominal pain, jaundice, to severe 
forms with liver failure. 
Several studies have shown a positive association 
between SC and a history of jaundice as a manifestation of 
acute infection. Moreover, one study suggested that those 
who presented with jaundice as a manifestation of acute 
infection have a 3-4 times greater chance of spontaneous 
clearance than those who developed asymptomatic 
infection [32]. 
Although the virus exhibits tropism for the liver tissue, 
the way it affects the hepatocytes is mainly indirect, via the 
host's immune system, which is stimulated by the presence 
of surface antigens found in the structure of the viral 
envelope. The direct action on the hepatocyte is limited, 
insignificant in the pathogenesis of liver injury. In this 
sense, the presence of jaundice in the acute phase may 
suggest an extensive liver injury, determined by a more 
competent immune system that is able to eliminate the 
virus from the organism. 
1.5. Age 
Regarding the relationship between the age of infection 
and the spontaneous viral clearance, the data is quite 
limited and the conclusions are drawn more indirectly. In 
this sense, considering that as the organism gets older, the 
chances of developing comorbidities that reduce the 
immune system's ability to clear the body of this pathogen 
increase (for example, diabetes, cancers, alcohol 
consumption, co-infection with other viruses, menopause, 
other) and the chances of SC are lower [33]. 
Studies carried out in young people who developed this 
infection due to repeated transfusions for hemophilia 
showed that the highest rate of spontaneous clearance was 
among the children who got the infection within the first 
two years of life, compared to those who got infected after 
the age of two [34].  
However, given that the children were infected during 
transfusions, and that this therapy is weight dependent, 
the higher rate of SC in them may have been due to 
inoculation of smaller amounts of the pathogen, 
compared to adults who received larger quantities of 
transfused products. The complex relationship between 
age and viral SC is not fully understood, and significant 
conclusions cannot yet be drawn. 
2. Environmental factors 
2.1. Frequency of contact with an HCV source 
Hepatitis C Virus is a blood-borne virus, which is 
transmitted in most cases parenterally, through contact 
with contaminated objects. Nowadays the most common 
vector of transmission is represented by the instruments 
used for drug administration, iatrogenic infection being an 
exception. 
Therefore, it is understandable why repeated contact 
with a contaminated instrument (for example, a needle 
used for heroin administration), which has been used by 
other infected individuals, is associated with a reduction in 
the incidence of SC. In contrast, one time-contact with the 
source has been associated with higher odds of viral 
clearance, especially among illicit drug users. In that case, 
we can safely assume that drug use cessation is positively 
associated with this clinical outcome of the infection 
[35,36]. 
2.2. Co-infection with other viruses 
Co-infection with other pathogens can alter the course 
of HCV infection. Simultaneous infection with 
immunosuppressive viruses, for example, Human 
Immunodeficiency Virus (HIV), is correlated with almost 
zero chance of SC. In contrast to this, an interesting 
observation was made in patients with chronic C hepatitis 
that developed acute co-infection with Hepatitis B and A 
virus, where the rate of spontaneous viral clearance was 
increased.  The mechanism behind these events is based on 
complex immune interactions. It seems that acute 
superinfection with the hepatitis A and B virus in patients 
already infected with the C virus inhibits not only viral 
replication but also stimulates the immune system in a 
manner dependent on IFN and TNF alpha, succeeding in C 
viral eradication in an impressing proportion of patients 
[37-39]. 
3. Viral factors 
HCV is characterized by impressive genetic variability. 
Depending on the nucleotide sequences in its RNA, six 
major genotypes are described. Within the same genotype, 
several subtypes are described, their number exceeding 100 
[1,40]. The genotypes have a geographical distribution, 
which is why it is difficult to analyze the relationship 
between SC and the viral genotype, given the fact that the 
studies are performed on patients from a geographical 
region, in which a particular type of viral genome 
predominates. This fact sustains the research directions for 
therapy development according to genotypes particularities 
[41-45]. 
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Highlights 
✓ Chronic HCV infection is a significant cause of 
morbidity and mortality. For the majority of cases, 
acute infection evolves into a chronic one which, left 
untreated, can lead to liver cirrhosis as well as other 
complications. 
✓ Spontaneous viral clearance is a rare clinical event 
occurring in approximately 20-30% of patients with 
HCV infection. Such clearance occurs in most cases 
within the first six months after initial exposure but 
may occur during the chronic stage of infection. 
✓ This favourable clinical outcome is determined by a 
true constellation of factors that act in a complex 
dynamism. 
Conclusions 
Spontaneous viral clearance is a rare clinical event 
occurring in approximately 20-30% of patients with HCV 
infection. SC appears in most cases within the first six 
months after initial exposure but may occur during the 
chronic stage of infection. It represents an extremely 
favourable clinical outcome, which is why patients 
consider themselves "lucky", but the course of the disease 
is determined not by luck but by a real constellation of 
factors that act in a complex dynamism. 
We conclude that the presence of the IL-28B variant 
type CC, the female sex, the aboriginal and Asian race, the 
history of jaundice as manifestation of the acute infection, 
young age at exposure, acute superinfection with the 
hepatitis A and B virus, and unique contact with a HCV 
source are favourable factors in the appearance of 
spontaneous viral clearance.  
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